Mobile apps for quick adverse drug reaction report: A scoping review-Reference-Cited by-同舟云学术

Mobile apps for quick adverse drug reaction report: A scoping review

Published:2022-09-30 Issue:1 Volume:32 Page:19-27
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiology and Drug

Author:

Parracha Edna Ribeiro¹^ORCID,Advinha Ana Margarida²³⁴^ORCID,Lopes Manuel José²³⁵^ORCID,Oliveira‐Martins Sofia¹²^ORCID

Affiliation:

1. Faculty of Pharmacy University of Lisbon Lisboa Portugal

2. CHRC – Comprehensive Health Research Centre Lisboa Portugal

3. Center and North Alentejo Regional Unit of Pharmacovigilance University of Évora Evora Portugal

4. School of Health and Human Development University of Évora Evora Portugal

5. School of Nursing São João de Deus University of Évora Evora Portugal

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5542

Reference52 articles.

1. World Health Organization. Regulation and Prequalification. Accessed 7 September 2021.https://www.who.int/teams/regulation‐prequalification/regulation‐and‐safety/pharmacovigilance.

2. European Medicines Agency.Module VI – Collection management and submission of reports of suspected adverse reactions to medicinal products (Rev 2). Guideline on good pharmacovigilance practices (GVP). 2017:144.

3. VigiBase, the WHO Global ICSR Database System: Basic Facts

4. Guideline on good pharmacovigilance practices (GVP).Module IX Addendum I – methodological aspects of signal detection from spontaneous reports of suspected adverse reactions. 2017. Accessed 10 September 2021.https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-gvp-module-ix-addendum-i-methodological-aspects-signal_en.pdf.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspective Chapter: Constant Need for Pharmacovigilance Improvement in Bosnia and Herzegovina;Pharmacovigilance - Facts, Challenges, Limitations and Opportunity [Working Title];2024-09-10

2. Evaluation of the Med Safety mobile app for reporting adverse events in Burkina Faso;Drugs & Therapy Perspectives;2024-07-27

3. Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study;Cancer Immunology, Immunotherapy;2024-05-11

4. Improving Drug Safety in Pediatric and Young Adult Patients with Hemato-Oncological Diseases: A Prospective Study of Active Pharmacovigilance;Pharmaceuticals;2024-01-12

5. Enhancing Pharmacovigilance in Côte d'Ivoire: Impact of GSK’s Training and Mentoring Pilot Project in the Abidjan Region;Drug Safety;2023-11-15